Category

Daily Briefs

Daily Brief Health Care: Mandi, Futura Medical, Lumexa Imaging Holdings, Sumitomo Pharma and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Mandi Inc Pre IPO: Hair Will Help Carry Weight to Future Growth, Pipeline Key
  • Friday Take Away: 21 November 2025
  • Lumexa Imaging Holdings, Inc. (LMRI): Peeking at the IPO Prospectus of a Diagnostic Imaging Service
  • 2026 High Conviction: Sumitomo Pharma (4506 JP) – Enzomenib Progress and Reboot Strategy Hold Key


Mandi Inc Pre IPO: Hair Will Help Carry Weight to Future Growth, Pipeline Key

By Tina Banerjee

  • Mandi has filed for a Hongkong IPO. The company which at present operates as a subsidiary of 3SBio Inc will be spun off and separately listed.
  • Mandi intends to use the IPO proceeds for funding product expansion, enhance early-stage R&D capabilities, invest in sales and marketing initiatives and, for working capital and general corporate purposes.
  • Minoxidil will be the main growth catalyst for now cashing on its leadership position while accelerating the development and commercialization of the pipeline assets will be key for future growth.

Friday Take Away: 21 November 2025

By Hybridan

  • Futura Medical specialises in the development and commercialisation of innovative sexual health products.
  • The lead product is Eroxon, which is a clinically proven treatment for erectile dysfunction.
  • In November 2025, £2.75m was raised at 1p and the shares are down from a 52 week high of 34p. 

Lumexa Imaging Holdings, Inc. (LMRI): Peeking at the IPO Prospectus of a Diagnostic Imaging Service

By IPO Boutique

  • Lumexa Imaging, one of the nation’s largest outpatient imaging providers, could join the limited group of IPOs expected to debut in December 2025.
  • The company operates 184 centers across 13 states, benefiting from strong population growth markets and a broad, diversified referring-physician network.
  • Backed by WCAS and supported by scalable technology and growing advanced imaging demand, Lumexa shows steady revenue momentum ahead of a potential year-end IPO.

2026 High Conviction: Sumitomo Pharma (4506 JP) – Enzomenib Progress and Reboot Strategy Hold Key

By Tina Banerjee

  • Sumitomo Pharma (4506 JP) will present updated clinical trial data of Enzomenib (for AML) and Nuvisertib (for Meylofibrosis). Both drug candidates hold strong future potential.
  • The company revised FY26 revenue guidance upward to ¥429B backed by continued strong sales in North America (+56% to ¥163B). Orgovyx witnessed solid patient growth while Gemtesa improved market share.
  • After largely remaining beaten down in the past few years Sumitomo stock has only begun to gain momentum in recent past. We feel it has still got an upside potential.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Dawning Information Industry C, Meesho, TSMC (Taiwan Semiconductor Manufacturing) – ADR, Intel Corp, WRKR, JD Industrial Technology , Kioxia Holdings , Kyivstar Group and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • SSE50 Index Rebalance: 4 Changes a Side & US$2.2bn Trade
  • Meesho IPO | Seller Operations and Nuances | India Internet Dynamics
  • Taiwan Dual-Listings Monitor: TSMC ADR Spread Deeper in Historically Rare Zone
  • Apple’s 18A Test Case Is the Inflection Intel Needed
  • WRKR Ltd – Solid Q1 FY26 with investment to ramp up
  • Pre-IPO JD Industrials (PHIP Updates) – Business Model, Peer Comparison, Forecast and Valuation
  • ECM Weekly (1 December 2025)-Kioxia, Airtel, Nippon, Toyoda Gosei, SBI Shinsei, NS Group, Super Bank
  • Kyivstar (KYIV US): New Starlink Direct to Cell Net Positive for Market Position


SSE50 Index Rebalance: 4 Changes a Side & US$2.2bn Trade

By Brian Freitas


Meesho IPO | Seller Operations and Nuances | India Internet Dynamics

By Pranav Bhavsar

  • Profitable Arbitrage: Generates positive FCF by monetizing logistics spreads (Valmo) and ad-tech, effectively acting as a profitable toll booth for unorganized retail rather than a traditional commission-based marketplace.
  • The Moat: Monopolizes “India 2” (<INR 300 AOV) via low-cost logistics infrastructure, creating a defensive barrier against Amazon and Flipkart’s higher-cost premium models.
  • Downside Risk: Supply-side flywheel is fragile; high return rates driving seller churn could pose significant threats to long-term sustainability.

Taiwan Dual-Listings Monitor: TSMC ADR Spread Deeper in Historically Rare Zone

By Vincent Fernando, CFA

  • TSMC: +27.1% Premium; Increased to More Historically Extreme Level; Deeper in Short Range
  • UMC: +2.3% Premium; Good Level to Open a Short of The Spread
  • ASE: +2.3% Premium; Wait Better Long Opportunity Near Parity or Below

Apple’s 18A Test Case Is the Inflection Intel Needed

By Raghav Vashisht

  • Multiple industry checks now indicate that Apple is preparing to source its entry-level M-series processors from Intel’s 18A node with EMIB-T packaging as early as 2027.
  • The revenue impact will be modest, but the signalling value is enormous: Apple does not hand out advanced-node access unless the foundry roadmap is de-risked.
  • This development aligns directly with the structural shifts we’ve been highlighting; Intel’s packaging-first wedge, foundry credibility, and TSMC’s overcapacity creating space for second-sourcing.

WRKR Ltd – Solid Q1 FY26 with investment to ramp up

By RaaS Research Group (RaaS)

  • Wrkr Ltd (ASX:WRK) offers compliance solutions for Australian superannuation contributions and payroll including member onboarding, super payments, messaging and employee validation.
  • WRK has delivered a record cash receipts quarter ($4.0m), +74% on the previous corresponding period (pcp) and +30% on Q4 FY25, aided by milestone payments and some overdue receipts from Q4 FY25 ($0.4m).
  • Total costs increased 24% on Q4 FY25 as WRK prepares for client onboarding and continues product development.

Pre-IPO JD Industrials (PHIP Updates) – Business Model, Peer Comparison, Forecast and Valuation

By Xinyao (Criss) Wang

  • JD Industrials’ business model integrates the advantageous resources of JD Group and follows “self-operated heavy asset” route.The operation model is to rely on JD Logistics network to achieve efficient performance.
  • The platform’s openness of JD Industrials is relatively limited. The entry and listing thresholds for merchants are higher than that of peers, which limits the rapid expansion of product richness.
  • P/S is more appropriate because net profit fluctuates greatly and is more suitable for growth-oriented supply chain companies.JD Industrials’ valuation could be higher than ZKH but lower than Ww Grainger.   

ECM Weekly (1 December 2025)-Kioxia, Airtel, Nippon, Toyoda Gosei, SBI Shinsei, NS Group, Super Bank

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, busy season remains on in full swing going into the year end.
  • On the placements front, there were a few large deals across the region.

Kyivstar (KYIV US): New Starlink Direct to Cell Net Positive for Market Position

By Vincent Fernando, CFA

  • Kyivstar Group (KYIV US) launched Starlink Direct to Cell on November 24, making Ukraine the first European country with commercial satellite connectivity to mobile phones.
  • Satellite connectivity provides Kyivstar a differentiated capability that should be positive for customer churn management given the ‘insurance value’ of having satellite backup connectivity for Ukrainians.
  • Kyivstar’s Starlink partnership is a net positive for the shares. We reiterate our Structural Long rating and US$19.8 target price. KYIV shares are trading at just 5.1x 2025E EV/EBITDA.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Kuang-Chi Technologies , ANE Cayman Inc, Low Keng Huat Singapore, Qube Holdings, Wuhu Conch Profiles And Science Co.,, Enviri, Aiphone Co Ltd and more

By | Daily Briefs, Industrials

In today’s briefing:

  • CSI300 Index Rebalance: 11 Changes & US$7.77bn Trade
  • ANE (9956 HK): Precondition Satisfied
  • Low Keng Huat (LKH SP): Conditional VGO at S$0.72 May Need a Bump
  • Low Keng Huat (LKH SP)’s Clean MBO
  • ANE (9956 HK): Pre-Cons Satisfied. Possible Payment Early March
  • (Mostly) Asia M&A, Nov 2025 Wrap: Qube, Forum Engineering, National Storage REIT, Star Micronics
  • Primer: Wuhu Conch Profiles And Science Co., (000619 CH) – Nov 2025
  • Weekly Update (NVRI, MRP, IAC)
  • (28 Nov 2025) Aiphone Co Ltd(6718 JP) — Fisco Company Research


CSI300 Index Rebalance: 11 Changes & US$7.77bn Trade

By Brian Freitas


ANE (9956 HK): Precondition Satisfied

By Arun George

  • The precondition for the consortium’s privatisation offer for ANE Cayman Inc (9956 HK) has been satisfied. The right to increase the share alternative cap was also satisfied. 
  • The consortium has until 12 December to decide whether to increase the share cap. The option helps the consortium gain support from shareholders who would not accept the cash offer. 
  • The scheme vote remains low risk, as the offer is attractive relative to historical ranges and peer multiples. The de-rating of peers is also helpful. 

Low Keng Huat (LKH SP): Conditional VGO at S$0.72 May Need a Bump

By Arun George

  • Low Keng Huat Singapore (LKH SP) has disclosed a voluntary conditional offer from the Managing Director at S$0.72 per share, a 17.1% premium to the last close price. 
  • While the offer represents an all-time high, it is below net asset value (implying a P/NAV of 0.91x). It is also light compared to precedent transactions. 
  • The offer price has not been declared final. A bump may be needed to satisfy the 90% minimum acceptance condition.

Low Keng Huat (LKH SP)’s Clean MBO

By David Blennerhassett

  • Late Friday (28th November), general building contractor Low Keng Huat Singapore (LKH SP) (“LKH”) announced a voluntary conditional Offer from Dato’ Marco Low Peng Kiat, LKH’s controlling shareholder (54.13%).
  • Low is offering S$0.72/share, a so-so 17.1% premium to undisturbed, but a decade-high price. Plus the share price is up 104% YTD. Recent results (to 31st July) were also underwhelming.
  • The Offer has a 90% acceptance hurdle condition. Low does not intend to maintain listing. The price hasn’t been declared final, possibly leading to a bump in the home stretch. 

ANE (9956 HK): Pre-Cons Satisfied. Possible Payment Early March

By David Blennerhassett

  • Back on the 28th October, ANE Cayman (9956 HK), a road freight transportation play, announced an Offer from Centurium Partners, a pre-IPO investor, Temasek, and Singapore-based asset manager True Light.
  • The consortium offered HK$12.18/share (best & final) via a Scheme, a 48.54% premium to undisturbed. A scrip alternative (mix & match) was also afforded. Plus a special dividend bolted on.
  • Pre-Cons included SAMR signing off. With JPM as the FA, I previously concluded, given JPM’s recent track record, the reg process should be straightforward. Those pre-cons have now been satisfied.

(Mostly) Asia M&A, Nov 2025 Wrap: Qube, Forum Engineering, National Storage REIT, Star Micronics

By David Blennerhassett

  • For November 2025, eight new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$10bn.
  • The average premium for the new transactions announced (or first discussed) in November was ~31%, with a year-to-date average of ~48%.
  • The average premiums for transactions in 2024 (129 transactions), 2023 (117), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) were 43%, 39%, 41%, 33%, 31%, and 31%.

Primer: Wuhu Conch Profiles And Science Co., (000619 CH) – Nov 2025

By αSK

  • Wuhu Conch Profiles and Science Co., Ltd. is a leading manufacturer of plastic profiles and other building materials in China, facing a challenging domestic construction market. The company has diversified its product portfolio to include energy-saving and environmentally friendly materials, which presents a potential growth avenue.
  • The financial performance has been under pressure, with the company reporting net losses in recent years. This is largely attributable to the downturn in the Chinese real estate sector, which is a key end-market for its products.
  • Despite the current headwinds, the company’s strong brand recognition, extensive distribution network, and focus on technological innovation provide a solid foundation for future recovery and growth as the construction market stabilizes and demand for higher-value, specialized products increases.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Weekly Update (NVRI, MRP, IAC)

By Richard Howe

  • One market sector that hasn’t been lifted by the AI narrative is the oil and gas industry.
  • Enviri Corporation (NVRI) announced on November 21, 2025, that it had reached a definitive agreement to sell its Clean Earth specialty-waste business to Veolia for $3 billion while simultaneously preparing to spin off its remaining Harsco Environmental and Harsco Rail divisions into a new standalone public company called New Enviri.
  • NVRI reacted positively to the news.


(28 Nov 2025) Aiphone Co Ltd(6718 JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • Aiphone Co., Ltd. aims for a 10% or higher return on equity by 2032 through its 8th Medium-Term Management Plan.
  • The company projects net sales of ¥65,400 million and operating income of ¥4,500 million for the fiscal year ending March 2026, despite a temporary profit decline.
  • Aiphone holds a 61% share of the domestic intercom market and is expanding its product offerings while maintaining a strong financial position and stable dividends.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Dundee Precious Metals , Sigma Lithium, Ercros , Crude Oil, Murphy Oil Corp and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Gold Miners ETF (GDX US) Dec Rebalance Preview: Stock Price Moves Shrink Capping Trade
  • Primer: Sigma Lithium (SGML US) – Nov 2025
  • Bondalti-Ercros: From Regulatory Clearance to Shareholder Countdown
  • Oil futures: Brent tests weekly highs, WTI resumes after CME glitch
  • Murphy Oil Is Pushing Exploration Hard—What Hidden Resources Could It Unlock Next?


Gold Miners ETF (GDX US) Dec Rebalance Preview: Stock Price Moves Shrink Capping Trade

By Brian Freitas

  • The VanEck Gold Miners ETF/USA (GDX US) transitioned from the tracking the NYSE Arca Gold Miners Index to the MarketVector Global Gold Miners Index in September.
  • Dundee Precious Metals (DPM CN)‘s stock price has continued to move higher and is likely to be added to the index in December.
  • Stock moves over the last month have shrunk the capping trade massively. Estimated one-way turnover is 1.8% and the round trip trade is US$1.75bn.

Primer: Sigma Lithium (SGML US) – Nov 2025

By αSK

  • Pure-Play, Low-Cost Producer with Ambitious Growth: Sigma Lithium is a new, low-cost producer of high-purity, environmentally friendly lithium concentrate from its single asset, the Grota do Cirilo project in Brazil. The company is aggressively expanding, with plans to more than triple production capacity by the end of 2026, positioning it as a significant player in the EV battery supply chain.
  • Leveraged to a Volatile but Recovering Lithium Market: The company’s profitability is highly sensitive to lithium prices, which have been volatile after collapsing from 2022 highs. While the market has been oversupplied, projections suggest a tightening supply-demand balance from 2025 onwards, driven by robust EV and energy storage growth, which could provide significant tailwinds.
  • High-Risk, High-Reward Equity Profile: As a single-asset company in an emerging market with a short operational history, Sigma carries significant execution and geopolitical risks. However, its industry-leading cost structure, strong ESG credentials, and aggressive, funded expansion plan offer substantial upside potential for investors with a high-risk tolerance.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Bondalti-Ercros: From Regulatory Clearance to Shareholder Countdown

By Jesus Rodriguez Aguilar

  • Spain’s Ministry of Economy has validated the CNMC’s conditional approval of Bondalti’s €3.505/share bid, removing all regulatory risk and shifting the focus entirely to CNMV processing, acceptance, and deal execution.
  • Ercros’s deteriorating fundamentals and thin liquidity heighten shareholder-acceptance uncertainty; ~75% tender is required, while prior minority opposition and elevated trough-cycle multiples complicate the risk-reward despite regulatory de-risking.
  • With shares at €3.30, the spread has compressed to ~6%, offering a short-dated carry trade with a 45–55% annualised IRR if settlement occurs by February 2026, versus a €2.56 break.

Oil futures: Brent tests weekly highs, WTI resumes after CME glitch

By Quantum Commodity Intelligence

  • Crude oil futures Friday were little changed although Brent tested weekly highs as doubts grow on the prospects for a Russia-Ukraine settlement.
  • Front-month Jan26 ICE Brent  futures were trading at $63.33/b (1854 GMT) versus Thursday’s settle of $63.34/b, but off from the week’s high of $63.76/b.
  • Jan26 NYMEX WTI was at $59.21/b , after trade resumed following a technical glitch.

Murphy Oil Is Pushing Exploration Hard—What Hidden Resources Could It Unlock Next?

By Baptista Research

  • Murphy Oil Corporation’s third quarter 2025 earnings report indicates a mix of robust operational results tempered by strategic caution amid market volatility.
  • The company surpassed its production guidance for the second consecutive quarter, reaching a total production of 200,000 barrels of oil equivalents per day.
  • This was bolstered by a strong showing in oil production, averaging 94,000 barrels per day.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Toyota Industries, Toyota Motor, TSE Tokyo Price Index TOPIX, Choice Hotels Intl, Meituan, Taste Gourmet and more

By | Consumer, Daily Briefs

In today’s briefing:

  • [Japan M&A] Toyota Inds (6201) – Process ALWAYS Bad, Price Bad To Worse; Easily Worth ¥20k+
  • Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (1 Dec)
  • Criticism of Shareholder Proposals from Activist Investors Is a Comforting Word for Management
  • Choice Hotels Reveals What’s Inside Its Bold Global Expansion Strategy!
  • Meituan (3690 HK): 3Q25, Discount Campaign Not Ended After Authorities Warned Twice
  • Taste Gourmet (8371 HK) H1 FY26 Earnings: 6.8x PE with 8.6% Yield, Cash Now 31% of Market Cap


[Japan M&A] Toyota Inds (6201) – Process ALWAYS Bad, Price Bad To Worse; Easily Worth ¥20k+

By Travis Lundy

  • In April there was a story suggesting Toyota Group would buy out Toyota Industries (6201 JP). In June, they announced a deal. It was a BAD DEAL.  
  • The price was low, but it was BAD governance because it was the WRONG DEAL. TICO’s Board declared a valuation fair for a deal not announced, ignoring the ACTUAL DEAL.
  • The valuation? Assumed no changes to the business. Actual deal? Sell 90+% of net assets driving 50% of net income, buy back 24+% of shares at discount. 

Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (1 Dec)

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlights: Currently twelve pair trade opportunities across four markets and five sectors persist.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

Criticism of Shareholder Proposals from Activist Investors Is a Comforting Word for Management

By Aki Matsumoto

  • Of foreign shareholding in 30% range, 1% is held by activist funds. Meanwhile, the cross-shareholding is around 10%, and ETFs held by BoJ account for 7% of TSE market capitalization.
  • Passing shareholder proposals remains difficult, as conditions must align: a company must have fairly high foreign ownership, and its conduct must be bad that domestic institutions can endorse the proposal.
  • Claiming that “shareholder proposals from activist investors often target short-term profit-seeking initiatives” merely serves as a comforting excuse for executives who are postponing management challenges.

Choice Hotels Reveals What’s Inside Its Bold Global Expansion Strategy!

By Baptista Research

  • Choice Hotels International’s recent earnings call provides an intricate overview of the company’s financial performance and strategic initiatives during the third quarter of 2025.
  • The company reported a 7% increase in adjusted EBITDA, reaching $190 million, primarily driven by an enhanced brand mix and increased business from small and medium enterprises and group bookings.
  • However, the positive financial performance was countered by a flat global RevPAR compared to the prior year, with a notable dip of 3.2% in the U.S. market owing to softer government and international inbound demand.

Meituan (3690 HK): 3Q25, Discount Campaign Not Ended After Authorities Warned Twice

By Ming Lu

  • Meituan (MT)’s revenue growth rate plummeted to 2% YoY in 3Q25.
  • The discount campaign has not actually ended after the authorities warned twice.
  • We expect that MT’s price has a downside of 30% in the next twelve months.

Taste Gourmet (8371 HK) H1 FY26 Earnings: 6.8x PE with 8.6% Yield, Cash Now 31% of Market Cap

By Sameer Taneja

  • Taste Gourmet (8371 HK) reported H1 FY26 results of Revenues/Pat 11.8% YoY/17.8%YoY. Profits were in line with our expectations as the company reined in costs and showed slight margin improvements. 
  • Cash continues to pile on the balance sheet, with 242 mn HKD of net cash representing >30% of market capitalization. The company paid an 8-cent semi-annual dividend.
  • The stock trades at a 6.8x PE for FY26e, has an 8.6% dividend yield, and plans to grow at a CAGR of at least 15%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: S&P/ASX 200, Qube Holdings and more

By | Australia, Daily Briefs

In today’s briefing:

  • Australia Single Stock Options (Nov 24– 27): Broad Rebound Pulls Implieds Lower
  • Last Week In Event SPACE: Qube Holdings, Digital Holdings, Wynn Resorts/Macau, SNT/SMEC


Australia Single Stock Options (Nov 24– 27): Broad Rebound Pulls Implieds Lower

By John Ley

  • SPASX200 gained steadily through the week despite slowing daily momentum, nearly reversing last week’s decline
  • Market breadth strengthened, with a broad rebound across optionable stocks.
  • Implied vols declined across most single stocks, bringing the average back toward mid range levels after last week’s elevated readings

Last Week In Event SPACE: Qube Holdings, Digital Holdings, Wynn Resorts/Macau, SNT/SMEC

By David Blennerhassett

  • This deal for Qube Holdings (QUB AU) from Macquarie should really get competitive. Scarce and strategic assets  – and nothing else like it that’s listed. 
  • As Digital Holdings (2389 JP) goes higher, “This is Japan” risk increases; but those who didn’t sign up say “wait a minute, that’s real money” also goes up.
  • Wynn Resorts (WYNN US) is at extreme levels vs. Wynn Macau Ltd (1128 HK); yet consensus indicates considerably higher forward EBITDA growth for Resorts stub ops vs. Macau.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Duolingo, Klarna Group, Louisiana Pacific, Parsons Corp and more

By | Daily Briefs, United States

In today’s briefing:

  • Duolingo Inc: Massive Advances in Adaptive Learning Technology & Key Growth Levers!
  • Klarna Group (NYSE: KLAR): 3Q’25 Quarterly Update, 4Q Guidance Trajectory Looks Strong
  • Louisiana-Pacific: How Far Can Its ExpertFinish Capacity Surge Push the Stock?
  • Parsons: What Is Its Strategy To Capture Explosive Growth in Defense, Cyber, & Infrastructure?


Duolingo Inc: Massive Advances in Adaptive Learning Technology & Key Growth Levers!

By Baptista Research

  • Duolingo’s third quarter results reflect both strengths and areas of potential concern for investors.
  • The company continues to show robust daily active user (DAU) growth, with a stated 36% year-over-year increase for Q3.
  • Current guidance projects nearly $1.2 billion in bookings by year-end with 33% growth and an adjusted EBITDA margin of 29%.

Klarna Group (NYSE: KLAR): 3Q’25 Quarterly Update, 4Q Guidance Trajectory Looks Strong

By Andrei Zakharov

  • Klarna Group had a successful IPO in September, but shares were volatile in October and November along with Affirm Holdings and other BNPL market players.
  • A Swedish first mover in the BNPL space went public at $40.00 per share, raising ~$169M of net proceeds. Selling shareholders offloaded ~$1.2B worth of Klarna Group shares.  
  • Klarna Group reported record results in 3Q as a public company, surpassing analyst expectations. However, net loss widened to $95M and provisions for credit losses jumped.

Louisiana-Pacific: How Far Can Its ExpertFinish Capacity Surge Push the Stock?

By Baptista Research

  • The third quarter of 2025 earnings report for Louisiana-Pacific Corporation (LP) presents a mixed picture, reflecting both strategic advancements and ongoing challenges.
  • On the positive side, LP’s Siding business showed resilience in a soft market, with a 5% increase in sales revenue driven primarily by pricing and a favorable mix.
  • Notably, the ExpertFinish prefinished siding product, with a 17% increase in sales volume, has contributed significantly, buoyed by the successful launch of a new line of nature-inspired colors.

Parsons: What Is Its Strategy To Capture Explosive Growth in Defense, Cyber, & Infrastructure?

By Baptista Research

  • Parsons Corporation reported its third-quarter 2025 financial results, emphasizing robust performance in a challenging global environment.
  • The company showcased strategic positioning and strong alignment with global priorities in national security and infrastructure.
  • This quarter, the company demonstrated significant achievements in organic revenue growth, expansion in adjusted EBITDA margins, exceeded cash flow expectations, and secured pivotal contracts.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Tejas Networks Limited and more

By | Daily Briefs, India

In today’s briefing:

  • Primer: Tejas Networks Limited (TEJASNET IN) – Nov 2025


Primer: Tejas Networks Limited (TEJASNET IN) – Nov 2025

By αSK

  • Tejas Networks is poised for significant growth, driven by a substantial contract from BSNL to supply 4G/5G Radio Access Network (RAN) equipment for 100,000 sites, which has led to a more than threefold increase in annual revenue.
  • The company is a key beneficiary of the Indian government’s ‘Make in India’ and Production-Linked Incentive (PLI) schemes, which promote domestic manufacturing of telecom equipment and aim to reduce reliance on imports.
  • Despite the massive revenue ramp-up, the company faces significant risks related to customer concentration, negative operating and free cash flows, and high working capital requirements, leading to increased short-term borrowings.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Resonac Holdings – Improving Mix and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Resonac Holdings – Improving Mix, Expanding Margins, and a Clear Case for Re-Rating
  • DKSH Malaysia: Good Set of 3 Q Results
  • Raccoon Holdings, Inc. (3031 JP): 1H FY04/26 flash update
  • Primer: Onex Corp (ONEX CN) – Nov 2025
  • Open Text: What Hidden Advantage Fuels Its Cloud & Managed Services Expansion?
  • Parsons: What Is Its Strategy To Capture Explosive Growth in Defense, Cyber, & Infrastructure?
  • Jazz Pharmaceuticals Inside Story: How CNS & Oncology Deals Are Building a New Revenue Machine!
  • Primer: China Boqi Environmental Hol (2377 HK) – Nov 2025
  • Louisiana-Pacific: How Far Can Its ExpertFinish Capacity Surge Push the Stock?
  • Primer: Beijing Wkw Automotive Parts (002662 CH) – Nov 2025


Resonac Holdings – Improving Mix, Expanding Margins, and a Clear Case for Re-Rating

By Rahul Jain

  • Semiconductor segment drives structural margin expansion, now contributing over 100% of core profit with record Q3 performance.
  • Legacy Chemicals and Graphite remain weak, but consolidated EBITDA outlook for FY2026–27 strengthens on improving mix.
  • Forward valuation supports ¥8,000 target; Resonac trades at a discount to global semiconductor-materials peers despite rising semis exposure.

DKSH Malaysia: Good Set of 3 Q Results

By Punit Khanna

  • Revenues for 9 months up 7% while profits are up 7.5%
  • Margins improved across both divisions, Healthcare and Consumer. Working capital marginally increased.
  • 4th quarter is the best quarter for the company due to the festive season.

Raising Money for Persons with Disabilities in Singapore

For your kind consideration

This report has been prepared by Vriddhi Consulting, founded by Punit and Debjani Khanna. A portion of the research was contributed by Shubham Khanna, an individual on the autism spectrum. We are grateful to Smartkarma for providing a platform to share this research and amplify its impact.

All proceeds from the publication of this report will be donated to support people with disabilities in Singapore. If you find this report valuable, we invite you to support our campaign, “Raising Money for Persons with Disabilities in Singapore.” Every contribution directly benefits the Goh Chok Tong Enable Fund and qualifies for a 250% tax deduction for Singapore tax residents.

To contribute, please visit this URL.


Raccoon Holdings, Inc. (3031 JP): 1H FY04/26 flash update

By Shared Research

  • Revenue increased by 2.7% YoY to JPY3.1bn, with EC business up 6.8% and Financial business down 2.6%.
  • Operating profit decreased 7.3% YoY to JPY575mn, with a 2.4pp rise in GPM and 4.3pp increase in SG&A ratio.
  • Financial business segment profit rose 7.2% YoY to JPY402mn, with external payments handled growing 11.2% YoY.

Primer: Onex Corp (ONEX CN) – Nov 2025

By αSK

  • Onex is a leading alternative asset manager with a long-term track record of value creation, primarily through its private equity and credit platforms. The firm is currently navigating a challenging macroeconomic environment by focusing on strategic acquisitions and a shift towards a more capital-light model.
  • A recent strategic partnership with AIG, including a significant capital commitment to Onex’s funds and AIG taking an equity stake, is expected to be transformational, enhancing the asset management platform’s profitability and accelerating growth in fee-generating assets under management (AUM).
  • Despite near-term headwinds in fundraising and volatile financial performance tied to the exit environment, the company’s disciplined capital allocation, including consistent share buybacks at a discount to intrinsic value, and a growing, scalable credit business, position it for potential long-term shareholder value creation.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Open Text: What Hidden Advantage Fuels Its Cloud & Managed Services Expansion?

By Baptista Research

  • Open Text Corporation has reported its financial results for the first quarter of fiscal 2026, demonstrating resilience and growth amidst a strategic shift.
  • The company’s total revenues reached $1.3 billion, a year-overyear increase of 1.5%, surpassing expectations due to strong demand in its Cloud and License segments.
  • Specifically, the Cloud segment, which generated $485 million in revenue, experienced a 6% growth year-overyear, primarily driven by the Content product category.

Parsons: What Is Its Strategy To Capture Explosive Growth in Defense, Cyber, & Infrastructure?

By Baptista Research

  • Parsons Corporation reported its third-quarter 2025 financial results, emphasizing robust performance in a challenging global environment.
  • The company showcased strategic positioning and strong alignment with global priorities in national security and infrastructure.
  • This quarter, the company demonstrated significant achievements in organic revenue growth, expansion in adjusted EBITDA margins, exceeded cash flow expectations, and secured pivotal contracts.

Jazz Pharmaceuticals Inside Story: How CNS & Oncology Deals Are Building a New Revenue Machine!

By Baptista Research

  • Jazz Pharmaceuticals reported a strong performance in the third quarter of 2025, achieving a record revenue surpassing $1.1 billion.
  • The growth was largely driven by solid sales from Xywav, Epidiolex, and the successful early launch of Modeyso.
  • These developments underscore the company’s ability to deliver highly differentiated therapies addressing serious unmet medical needs, which is an indication of strategic execution and robust operational capabilities.

Primer: China Boqi Environmental Hol (2377 HK) – Nov 2025

By αSK

  • Leading Market Position with Diversifying Business: China Boqi is a leading independent flue gas treatment provider in China, primarily serving the coal-fired power sector. The company is strategically diversifying into adjacent environmental sectors, including water treatment, hazardous and solid waste treatment, and dual-carbon energy-saving businesses, to capture broader market opportunities driven by China’s stringent environmental policies.
  • Attractive Valuation and Strong Dividend Yield: The company trades at a significant discount to the broader market, with a P/E ratio of approximately 3.75x and a P/B ratio of 0.28x. This is complemented by a consistent and growing dividend, yielding approximately 4.8%, making it an attractive proposition for value and income-oriented investors.
  • Regulatory Tailwinds vs. Transitional Risks: China’s national commitment to environmental protection and carbon neutrality provides a strong, long-term tailwind for the industry. However, the company faces risks associated with its legacy dependence on the coal power industry, intense market competition, and the execution of its diversification strategy into new, competitive fields.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Louisiana-Pacific: How Far Can Its ExpertFinish Capacity Surge Push the Stock?

By Baptista Research

  • The third quarter of 2025 earnings report for Louisiana-Pacific Corporation (LP) presents a mixed picture, reflecting both strategic advancements and ongoing challenges.
  • On the positive side, LP’s Siding business showed resilience in a soft market, with a 5% increase in sales revenue driven primarily by pricing and a favorable mix.
  • Notably, the ExpertFinish prefinished siding product, with a 17% increase in sales volume, has contributed significantly, buoyed by the successful launch of a new line of nature-inspired colors.

Primer: Beijing Wkw Automotive Parts (002662 CH) – Nov 2025

By αSK

  • Exceptional Profitability Growth Amidst Revenue Contraction: The company has demonstrated a remarkable ability to grow net income and EPS, with a 3-year CAGR exceeding 51%, despite a concurrent decline in revenues. This suggests a successful strategic shift towards higher-margin products, significant operational efficiencies, or divestiture of underperforming assets.
  • Strategic Positioning for the New Energy Vehicle (NEV) Transition: Beijing WKW is actively investing in and expanding its product lines to include components for electric vehicles (EVs). This forward-looking strategy positions the company to capitalize on the rapid growth of the NEV market in China, which is the largest and fastest-growing in the world.
  • Attractive Shareholder Returns and Valuation: The company exhibits strong value and dividend characteristics, underscored by high Smartkarma scores in these categories. A consistent dividend yield, which stood at 1.86% in the most recent fiscal year, combined with a reasonable valuation, presents an attractive proposition for value-oriented investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Japan Strategy Weekly | Thanksgiving Rally and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Strategy Weekly | Thanksgiving Rally
  • APAC Healthcare Weekly (November 30) – Kelun Bio, ImmuneOnco, Otsuka, Eisai, Alteogen, SK Biopharma


Japan Strategy Weekly | Thanksgiving Rally

By Mark Chadwick

  • Japanese equities rebounded strongly this week, with the Nikkei 225 up 3.3% and TOPIX up 2.4%, nearly reversing the prior week’s sharp losses.
  • This week’s top performer was Toppan Printing due to strong interest in its “Double View Film” for solar panels and a new data-driven customer-experience service, highlighting innovation and growth potential.
  • A quieter week for Activists. Dalton increased its Anicom stake to 9.5%, signalling confidence in the pet insurer’s stable growth and potential capital returns.

APAC Healthcare Weekly (November 30) – Kelun Bio, ImmuneOnco, Otsuka, Eisai, Alteogen, SK Biopharma

By Tina Banerjee

  • Sichuan Kelun-Biotech announces Phase 3 trial success for ADC-Keytruda combination therapy in first-line lung cancer. ImmuneOnco received Phase 3 trial approval for IMM0306 lenalidomide combination for follicular lymphoma in China.
  • Otsuka received FDA accelerated approval of Voyxact for immunoglobulin A nephropathy. Eisai has completed FDA submission of Leqembi Iqlik subcutaneous autoinjector as a weekly starting dose for early Alzheimer’s disease.
  • Alteogen secures $15M milestone payment from Merck as Keytruda subcutaneous formulation gets EU approval. SK Biopharmaceuticals in-licenses second radiopharmaceutical candidate, which has potential to target clear cell renal cell carcinoma.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars